InsiderTrades

Form 4 for TDOC Teladoc Health, Inc.

Accepted 2024-06-04 00:00:00 ET · period of report 2024-05-31 · accession 0001477449-24-000152 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-06-04 2024-06-03 TDOC Waters Michael Willem COO S - Sale+OE $11.16 -4,246 68.9K -6% -$47.4K
DM 2024-06-04 2024-05-31 TDOC Waters Michael Willem COO M - OptEx — +8,313 67.0K +14% —
DM 2024-06-04 2024-05-31 TDOC Waters Michael Willem COO M - OptEx $0.00 -8,313 43.4K -16% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-06-03 S D 4,246 $11.16 68,948 D — — (F3) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
2 Common Common Stock 2024-05-31 M A 6,200 — 73,194 D — — (F2) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
3 Common Common Stock 2024-05-31 M A 2,113 — 66,994 D — — (F1) Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
4 Derivative Performance Stock Units 2024-05-31 M D 2,113 $0.00 14,792 D — · — to — 2,113 Common Stock (F1) Performance stock units convert to shares of TDOC common stock on a one-for-one basis. (F4) On March 1, 2024, the reporting person earned 25,357 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
5 Derivative Restricted Stock Units 2024-05-31 M D 6,200 $0.00 43,404 D — · — to — 6,200 Common Stock (F2) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F5) On March 3, 2023, the reporting person was granted 74,405 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.